Evidence map›Paper›PMID 41540146›Full record

ArticlePsychopharmacology2026

Effects of morphine self-administration on brain structure and microglial phenotypic diversity in the absence of neuronal loss in male Wistar rats.

Ana Débora Elizarrarás-Herrera, David Medina-Sánchez, Mariana Stefania Serrano-Ramírez, Diego Angeles-Valdez, Luis A Trujillo-Villarreal, María Antonieta Carbajo-Mata, César J Carranza-Aguilar, Eduardo A Garza-Villarreal

Abstract read
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ana Débora Elizarrarás-Herrera *Instituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM) campus Juriquilla, Laboratorio D-12, Boulevard Juriquilla 3001, Santiago de Querétaro, C.P. 76230, Querétaro, México.ORCID http://orcid.org/0009-0003-8057-7482
David Medina-Sánchez *Instituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM) campus Juriquilla, Laboratorio D-12, Boulevard Juriquilla 3001, Santiago de Querétaro, C.P. 76230, Querétaro, México.ORCID http://orcid.org/0000-0001-7608-0244
Mariana Stefania Serrano-RamírezInstituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM) campus Juriquilla, Laboratorio D-12, Boulevard Juriquilla 3001, Santiago de Querétaro, C.P. 76230, Querétaro, México.ORCID http://orcid.org/0009-0000-7232-9073
Diego Angeles-ValdezInstituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM) campus Juriquilla, Laboratorio D-12, Boulevard Juriquilla 3001, Santiago de Querétaro, C.P. 76230, Querétaro, México.ORCID http://orcid.org/0000-0001-8029-8369
Luis A Trujillo-VillarrealInstituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM) campus Juriquilla, Laboratorio D-12, Boulevard Juriquilla 3001, Santiago de Querétaro, C.P. 76230, Querétaro, México.ORCID http://orcid.org/0000-0002-8246-3054
María Antonieta Carbajo-MataInstituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM) campus Juriquilla, Laboratorio D-12, Boulevard Juriquilla 3001, Santiago de Querétaro, C.P. 76230, Querétaro, México.ORCID http://orcid.org/0000-0002-8715-4197
César J Carranza-AguilarInstituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM) campus Juriquilla, Laboratorio D-12, Boulevard Juriquilla 3001, Santiago de Querétaro, C.P. 76230, Querétaro, México. cesarjcarranza@gmail.com.ORCID http://orcid.org/0000-0001-9117-1611
Eduardo A Garza-VillarrealInstituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM) campus Juriquilla, Laboratorio D-12, Boulevard Juriquilla 3001, Santiago de Querétaro, C.P. 76230, Querétaro, México. egarza@comunidad.unam.mx.ORCID http://orcid.org/0000-0003-1381-8648

Funding

CONAHCYT/SECIHTI 3256252/629578DGAPA 781759UNAM PAPIIT IA201622UNAM PAPIIT IN213924
6 · The paper itself

Abstract

rationaleOpioid addiction, including morphine use, is a major public health crisis in the U.S. It has been associated with brain volume changes in reward-related regions, neuronal loss, and neuroinflammation. While these alterations have been studied separately, it remains unclear whether structural changes co-occur with microglial adaptations at early stages of morphine use.

objectiveThis study aimed to examine region-specific brain volume changes, cellular counts, and the emergence of distinct microglial phenotypes in addiction-related regions, using a model of morphine self-administration that simulates the early phase of morphine consumption.

methodsMale Wistar rats were trained to self-administer morphine (0.01 mg/kg/inf) for 20 days in 3-hour daily sessions under operant conditioning. Structural MRI was conducted before and after the self-administration period, and brain volume was quantified using deformation-based morphometry. Brain tissue was immunolabeled for Iba1 and NeuN, and confocal microscopy images of microglia were analyzed using principal component analysis and K-means clustering.

resultsMorphine self-administration produced volume increases in the globus pallidus and reductions in the insular cortex. Microglial density was elevated in these regions and other addiction-related areas, including the caudate-putamen and dentate gyrus, without significant variations in neuronal count but with a marked reduction in neuronal soma size in these latter regions. Clustering revealed diverse microglial phenotypes, including intermediate morphologies, with region-dependent distributions indicative of diverse neuroinflammatory states.

conclusionsThese findings suggest that morphine-induced brain volume changes during the early stages of consumption are not attributable to neuronal loss but may reflect adaptive processes involving neuronal restructuring and microglial remodeling. Microglial phenotyping emerges as a sensitive approach for detecting neuroinflammatory patterns linked to addiction vulnerability.

Indexed as

AddictionAnimal modelBrain volumeDeformation-based morphometryMagnetic resonance imagingMicroglial morphologyMorphineNeuroinflammationOpioidsSelf-administration

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.